Back

SGLT2 inhibitor treatment for dystrophic cardiomyopathy: an animal experiment of CRISPR/Cas9-generated rat model with Duchenne muscular dystrophy

9 May 2026 (08:30 - 09:50)
Organised by: Logo
Congress Presentation Part of: ePosters in basic science (1) Cardiomyopathies Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Koichi Kimura

Institute of Medical Science - The University of Tokyo, Tokyo (Japan)

5 More presentations in this session

Presentation thumbnail
Relationship between lipoprotein(a) and renal function: evidence from a cross-sectional analysis
Doctor S. Azevedo (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Real-world treatment patterns and preferences in patients with transthyretin amyloid cardiomyopathy from Germany and Spain
Ms R. Knapp (Berlin, DE)
Abstract Slides
Presentation thumbnail
Different pathophysiological mechanisms during prolonged and moderate ischemia in pediatric cardiac surgery
Mr D. Verikas (Kaunas, LT)
Abstract Slides
Presentation thumbnail
Protein quality control pathways as modifiers of disease severity in PLN cardiomyopathy
Doctor K. Andrysiak (Groningen, NL)
Abstract Slides
Presentation thumbnail
Effect of renal denervation in a porcine model of myocardial infarction
Doctor D. Martinez-Falguera (Badalona, ES)
Abstract Slides

Access the full session

Session thumbnail
ePosters in basic science (1)

The Event

Event poster

Heart Failure 2026

9 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Session
When time is the issue
thumbnail
Congress Session
Genetics in heart failure
thumbnail
Congress Session
When external causes are the villain?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources